Garcia-Prats AJ, Frias M, van der Laan L, De Leon A, et al. Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial. Antimicrob Agents Chemother 2022 Apr 11:e0214421. doi: 10.1128/aac.02144.
PMID: 35404075